Berkshire Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Berkshire Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,700	Closed	-$55.8K	–	262
2025 Q3	$55.8K	Hold	17,700	–	–	﹤0.01%	296
2025 Q2	$40K	Hold	17,700	–	–	﹤0.01%	283
2025 Q1	$43K	Hold	17,700	–	–	﹤0.01%	280
2024 Q4	$52.7K	Hold	17,700	–	–	﹤0.01%	277
2024 Q3	$83.2K	Hold	17,700	–	–	﹤0.01%	278
2024 Q2	$83.2K	Buy	+17,700	New	+$85.3K	﹤0.01%	280

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Asset Management's ACHV Position: Q4 2025 in Review

Berkshire Asset Management sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 17,700 shares — an estimated $55.8K sold.

Berkshire Asset Management first reported a position in ACHV in Q2 2024 and held it in 6 quarters. The position peaked at $83.2K in Q3 2024. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

Berkshire Asset Management reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
Berkshire Asset Management sold 17,700 Achieve Life Sciences shares in Q4 2025, an estimated $55.8K.
Berkshire Asset Management first reported a position in Achieve Life Sciences in Q2 2024 and held it in 6 quarters.
Berkshire Asset Management's Achieve Life Sciences position peaked at $83.2K in Q3 2024.
77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on Berkshire Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.